Prefrontal β2 subunit-containing and α7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling

Journal of Neuroscience

Volumn 30, Issue 9, 2010, Pages 3518-3530

  Parikh, Vinay ^a,c   Ji, Jinzhao ^a   Decker, Michael W ^b   Sarter, Martin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ABBOTT LABORATORIES   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (2 PYRROLIDINYLMETHOXY)PYRIDINE; A 582941; BETA 2 ADRENERGIC RECEPTOR; BUNGAROTOXIN RECEPTOR; GLUTAMIC ACID; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; ACETYLCHOLINE; ALPHA-BUNGAROTOXIN RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; C57BL 6 MOUSE; CHOLINERGIC ACTIVITY; COGNITION; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; EVOKED RESPONSE; MALE; MICROELECTRODE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; ANIMAL; C57BL MOUSE; DENERVATION; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GENETICS; HISTOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SECRETION; SENSORY NERVE; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC TRANSMISSION; SYNAPTOSOME; THALAMUS; TIME; VENTRAL TEGMENTUM;

ACETYLCHOLINE; AFFERENT PATHWAYS; ANIMALS; DENERVATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINIC AGONISTS; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION; THALAMUS; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 77749306302     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5712-09.2010     Document Type: Article

References (82)

1. Arnold HM, Burk JA, Hodgson EM, Sarter M, Bruno JP (2002) Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention. Neuroscience 114:451- 460.
2. Bentley P, Driver J, Dolan RJ (2008) Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Brain 131:409-424.
3. Bitner RS, Bunnelle WH, Anderson DJ, Briggs CA, Buccafusco J, Curzon P, DeckerMW,Frost JM, Gronlien JH, Gubbins E, Li J, Malysz J, Markosyan S, Marsh K, MeyerMD,Nikkel AL, Radek RJ, RobbHM,Timmermann D, Sullivan JP, Gopalakrishnan M (2007) Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 27:10578 -10587.
4. Briand LA, Gritton H, Howe WM, Young DA, SarterM (2007) Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol 83:69 -91.
5. Buccafusco JJ, Jackson WJ, Terry AV Jr, Marsh KC, Decker MW, Arneric SP (1995) Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology (Berl) 120:256 -266.
6. Buccafusco JJ, Terry AV Jr, Decker MW, Gopalakrishnan M (2007) Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochem Pharmacol 74:1202-1211.
7. Buisson B, Bertrand D (2001) Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 21:1819 -1829.
8. Couey JJ, Meredith RM, Spijker S, Poorthuis RB, Smit AB, Brussaard AB, Mansvelder HD (2007) Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 54:73- 87.
9. Crick F (1984) Function of the thalamic reticular complex: the searchlight hypothesis. Proc Natl Acad Sci U S A 81:4586-4590.
10. Day BK, Pomerleau F, Burmeister JJ, Huettl P, Gerhardt GA (2006) Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J Neurochem 96:1626 -1635.
11. DeckerMW,BannonAW,Curzon P, Gunther KL, Brioni JD, HolladayMW,Lin NH,Li Y, Daanen JF, Buccafusco JJ, PrendergastMA,Jackson WJ, Arneric SP (1997) ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]. II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. J Pharmacol Exp Ther 283:247-258.
12. Deco G, Thiele A (2009) Attention: oscillations and neuropharmacology. Eur J Neurosci 30:347-354.
13. Dickinson JA, Kew JN, Wonnacott S (2008) Presynaptic α7- and β2 containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74:348 -359.
14. Disney AA, Aoki C, Hawken MJ (2007) Gain modulation by nicotine in macaque v1. Neuron 56:701-713.
15. Dunbar GC, Inglis F, Kuchibhatla R, Sharma T, Tomlinson M, Wamsley J (2007) Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI). J Psychopharmacol 21:171-178.
16. Dwoskin LP, Crooks PA (2001) Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther 298:395- 402.
17. 2+ signalling due to activation of α7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J Physiol 582:597- 611.
18. Franklin KBJ, PaxinosG (2008) The mouse brain in stereotaxic coordinates, Ed 3. San Diego: Academic.
19. Furey ML, Pietrini P, Haxby JV, DrevetsWC (2008) Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 33:913-923.
20. Gilbert D, Lecchi M, Arnaudeau S, Bertrand D, Demaurex N (2009) Local and global calcium signals associated with the opening of neuronal α7 nicotinic acetylcholine receptors. Cell Calcium 45:198 -207.
21. Gioanni Y, Rougeot C, Clarke PB, Lepous é C, Thierry AM, Vidal C (1999) Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci 11:18 -30.
22. Girod R, Barazangi N, McGehee D, RoleLW (2000) Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39:2715-2725.
23. Greenwald AG, Gonzalez R, Harris RJ, Guthrie D (1996) Effects sizes and p values: what should be reported and what should be replicated? Psychophysiology 33:175-183.
24. Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197-208.
25. Guldin WO, Pritzel M, Markowitsch HJ (1981) Prefrontal cortex of the mouse defined as cortical projection area of the thalamic mediodorsal nucleus. Brain Behav Evol 19:93-107.
26. Hahn B, Sharples CG, Wonnacott S, Shoaib M, Stolerman IP (2003) Attentional effects of nicotinic agonists in rats. Neuropharmacology 44:1054 -1067.
27. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA (2007) Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 27:3477-3489.
28. Hascup KN, Hascup ER, Pomerleau F, Huettl P, Gerhardt GA (2008) Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther 324:725-731.
29. Howe WM, Parikh V, Decker M, Sarter M (2009) Cognition enhancement by nAChR agonists: facilitation of cue detection based on augmented cholinergic transients in prefrontal cortex. Soc Neurosci Abstr 35:873.20.
30. Howe WM, Ji J, Parikh V, Williams S, Mocaer E, Trocme-Thibierge C, Sarter M (2010) Enhanced attentional performance by selective stimulation of α4β2* nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology. Advance online publication. Retrieved Feb. 10, 2010. doi:10.1038/npp.2010.9.
31. Hoyle E, Genn RF, Fernandes C, Stolerman IP (2006) Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 189:211-223.
32. Irle E, Sarter M, Guldin WO, Markowitsch HJ (1984) Afferents to the ventral tegmental nucleus of Gudden in the mouse, rat, and cat. J Comp Neurol 228:509 -541.
33. Kawai H, Lazar R, Metherate R (2007) Nicotinic control of axon excitability regulates thalamocortical transmission. Nat Neurosci 10:1168 -1175.
34. Kozak R, Bruno JP, SarterM (2006) Augmented prefrontal acetylcholine release during challenged attentional performance. Cereb Cortex 16:9 -17.
35. Kozak R, Martinez V, Young D, Brown H, Bruno JP, SarterM (2007) Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not nonperforming, rats. Neuropsychopharmacology 32:2074 -2086.
36. Lambe EK, Picciotto MR, Aghajanian GK (2003) Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28:216 -225.
37. Lemann W, Saper CB (1985) Evidence for a cortical projection to the magnocellular basal nucleus in the rat: an electron microscopic axonal transport study. Brain Res 334:339 -343.
38. Livingstone PD, Srinivasan J, Kew JN, Dawson LA, Gotti C, Moretti M, Shoaib M, Wonnacott S (2009) alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 29:539 -550.
39. Marks MJ, Wageman CR, Grady SR, Gopalakrishnan M, Briggs CA (2009) Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. Biochem Pharmacol 78:795- 802.
40. McGaughy J, Kaiser T, SarterM (1996) Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav Neurosci 110:247-265.
41. McGaughy J, Decker MW, Sarter M (1999) Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats. Psychopharmacology (Berl) 144:175-182.
42. Neigh GN, Arnold HM, Rabenstein RL, Sarter M, Bruno JP (2004) Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release. Neuroscience 123:635-645.
43. Neigh-McCandless G, Kravitz BA, Sarter M, Bruno JP (2002) Stimulation of cortical acetylcholine release following blockade of ionotropic glutamate receptors in nucleus accumbens. Eur J Neurosci 16:1259 -1266.
44. Newhouse PA, Potter A, Singh A (2004) Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4:36-46.
45. Oh JD, Woolf NJ, Roghani A, Edwards RH, Butcher LL (1992) Cholinergic neurons in rat central nervous system demonstrated by in situ hybridization of choline acetyltransferase mRNA. Neuroscience 47:807- 822.
46. Oldenziel WH, Dijkstra G, Cremers TI, Westerink BH (2006) In vivo monitoring of extracellular glutamate in the brain with a microsensor. Brain Res 1118:34-42.
47. Orr-Urtreger A, Göldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, Dani JA, Patrick JW, Beaudet AL (1997) Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17:9165-9171.
48. Paolone G, Ji J, Williams S, Howe WM, Ward J, Parikh V, Decker MW, Sarter M (2009) Effects of the selective α7 nAChR agonist ABT-107 on prefrontal glutamatergic and cholinergic activity and attentional performance. Soc Neurosci Abstr 35:227.5.
49. Parikh V, Sarter M (2006) Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J Neurochem 97:488 -503.
50. Parikh V, Sarter M (2008) Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann N Y Acad Sci 1129:225-235.
51. Parikh V, Pomerleau F, Huettl P, Gerhardt GA, Sarter M, Bruno JP (2004) Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels. Eur J Neurosci 20:1545-1554.
52. Parikh V, Kozak R, Martinez V, Sarter M (2007) Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56:141-154.
53. Parikh V, Man K, Decker MW, Sarter M (2008) Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J Neurosci 28:3769 -3780.
54. Parnas H, Slutsky I, Rashkovan G, Silman I, Wess J, Parnas I (2005) Depolarization initiates phasic acetylcholine release by relief of a tonic block imposed by presynaptic M2 muscarinic receptors. J Neurophysiol 93:3257-3269.
55. Paxinos G, Watson C (1988) The rat brain in stereotaxic coordinates, Ed 4. San Diego: Academic.
56. Pinault D (2004) The thalamic reticular nucleus: structure, function and concept. Brain Res Rev 46:1-31.
57. Pioli EY, Meissner W, Sohr R, Gross CE, Bezard E, Bioulac BH (2008) Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. Neuroscience 153:1213-1224.
58. Poorthuis RB, Goriounova NA, Couey JJ, Mansvelder HD (2009) Nicotinic actions on neuronal networks for cognition: general principles and longterm consequences. Biochem Pharmacol 78:668-676.
59. Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA (1999) Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology (Berl) 142:334 -342.
60. Quarta D, Naylor CG, Morris HV, Patel S, Genn RF, Stolerman IP (2007) Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine. Neuropharmacology 53:421- 430.
61. Radcliffe KA, Dani JA (1998) Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18:7075-7083.
62. Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts DL, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, Cox BF, Decker MW, Sullivan JP (2004) ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders. CNS Drug Rev 10:167-182.
63. Sarter M, Markowitsch HJ (1984) Collateral innervation of the medial and lateral prefrontal cortex by amygdaloid, thalamic, and brain-stem neurons. J Comp Neurol 224:445- 460.
64. Sarter M, Hasselmo ME, Bruno JP, Givens B (2005) Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Rev 48:98 -111.
65. Sarter M, Parikh V, Howe WM (2009a) nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. Biochem Pharmacol 78:658-667.
66. Sarter M, Parikh V, HoweWM (2009b) Phasic acetylcholine release and the volume transmission hypothesis: time to move on. Nat Rev Neurosci 10:383-390.
67. Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Xue IC, Piattoni-Kaplan M, Molinari E, Campbell JE, McKenna DG, Gunn DE, Lin NH, Ryther KB, He Y, Holladay MW, Wonnacott S, Williams M, Arneric SP (1997) ABT-089 [2-methyl-3-(2-( S)-pyrrolidinylmethoxy) pyridine]. I. A potent and selective cholinergic channel modulator with neuroprotective properties. J Pharmacol Exp Ther 283:235-246.
68. Timmerman W, Cisci G, Nap A, de Vries JB, Westerink BH (1999) Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis. Brain Res 833:150-160.
69. Turchi J, Sarter M (1997) Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Brain Res Cogn Brain Res 6:147-158.
70. von Engelhardt J, Eliava M, Meyer AH, Rozov A, Monyer H (2007) Functional characterization of intrinsic cholinergic interneurons in the cortex. J Neurosci 27:5633-5642.
71. Walsh H, Govind AP, Mastro R, Hoda JC, Bertrand D, Vallejo Y, Green WN (2008) Upregulation of nicotinic receptors by nicotine varies with receptor subtype. J Biol Chem 283:6022- 6032.
72. Weese GD, Phillips JM, Brown VJ (1999) Attentional orienting is impaired by unilateral lesions of the thalamic reticular nucleus in the rat. J Neurosci 19:10135-10139.
73. Wilens TE, DeckerMW (2007) Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol 74:1212-1223.
74. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D (1999) A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 156:1931-1937.
75. Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA (2006) ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry 59:1065-1070.
76. Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA (2009) Chronic nicotine selectively enhances α4β2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29:12428-12439.
77. Xu W, Orr-Urtreger A, Nigro F, Gelber S, Sutcliffe CB, Armstrong D, Patrick JW, Role LW, Beaudet AL, De Biasi M (1999) Multiorgan autonomic dysfunction in mice lacking the β2 and the β4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19:9298 -9305.
78. Yates SL, Bencherif M, Fluhler EN, Lippiello PM (1995) Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or alpha 4 beta 2 receptors to nicotine. Biochem Pharmacol 50:2001-2008.
79. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, Spratt C, Finlayson K, Sharkey J (2007) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17:145-155.
80. Zaborszky L, Gaykema RP, Swanson DJ, CullinanWE (1997) Cortical input to the basal forebrain. Neuroscience 79:1051-1078.
81. Zaborszky L, Buhl DL, Pobalashingham S, Bjaalie JG, Nadasdy Z (2005) Three-dimensional chemoarchitecture of the basal forebrain: spatially specific association of cholinergic and calcium binding proteincontaining neurons. Neuroscience 136:697-713.
82. Zmarowski A, Sarter M, Bruno JP (2005) NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. Eur J Neurosci 22:1731-1740.